【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 17
2 Introduction 18
2.1 Alzheimer Diagnostic Tests Overview 18
3 Products under Development 19
3.1 Alzheimer – Pipeline Products by Stage of Development 19
3.2 Alzheimer – Pipeline Products by Territory 20
3.3 Alzheimer – Pipeline Products by Regulatory Path 21
3.4 Alzheimer – Pipeline Products by Estimated Approval Date 22
3.5 Alzheimer – Ongoing Clinical Trials 23
4 Alzheimer – Pipeline Products under Development by Companies 24
4.1 Alzheimer Companies – Pipeline Products by Stage of Development 24
4.2 Alzheimer – Pipeline Products by Stage of Development 29
5 Alzheimer Companies and Product Overview 34
5.1 AC Immune SA Company Overview 34
5.1.1 AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview 34
5.2 Acobiom Company Overview 37
5.2.1 Acobiom Pipeline Products & Ongoing Clinical Trials Overview 37
5.3 Acumen Pharmaceuticals, Inc. Company Overview 40
5.3.1 Acumen Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.4 Adlyfe Inc. Company Overview 42
5.4.1 Adlyfe Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.5 Advanced Genomic Technology, LLC Company Overview 43
5.5.1 Advanced Genomic Technology, LLC Pipeline Products & Ongoing Clinical Trials Overview 43
5.6 ADx NeuroSciences NV Company Overview 44
5.6.1 ADx NeuroSciences NV Pipeline Products & Ongoing Clinical Trials Overview 44
5.7 Akrivis Technologies, LLC Company Overview 58
5.7.1 Akrivis Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 58
5.8 Alere Inc. Company Overview 59
5.8.1 Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.9 Alzhyme Pty Ltd Company Overview 61
5.9.1 Alzhyme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
5.10 Amarantus Bioscience Holdings, Inc. Company Overview 62
5.10.1 Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.11 Applied Proteomics, Inc. Company Overview 66
5.11.1 Applied Proteomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.12 Araclon Biotech, S.L. Company Overview 67
5.12.1 Araclon Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 67
5.13 Banyan Biomarkers, Inc. Company Overview 68
5.13.1 Banyan Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
5.14 BioArctic Neuroscience AB Company Overview 69
5.14.1 BioArctic Neuroscience AB Pipeline Products & Ongoing Clinical Trials Overview 69
5.15 biOasis Technologies Inc. Company Overview 70
5.15.1 biOasis Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.16 Biomedical Development Corporation Company Overview 71
5.16.1 Biomedical Development Corporation Pipeline Products & Ongoing Clinical Trials Overview 71
5.17 BioSystems International Company Overview 72
5.17.1 BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 72
5.18 C2N Diagnostics LLC Company Overview 73
5.18.1 C2N Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 73
5.19 Chronix Biomedical, Inc. Company Overview 74
5.19.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
5.20 Cognoptix, Inc. Company Overview 76
5.20.1 Cognoptix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
5.21 Columbia University Company Overview 80
5.21.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 80
5.22 CompanDX Ltd. Company Overview 83
5.22.1 CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview 83
5.23 Consejo Superior de Investigaciones Cientificas Company Overview 84
5.23.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 84
5.24 Cymedx Company Overview 86
5.24.1 Cymedx Pipeline Products & Ongoing Clinical Trials Overview 86
5.25 DiaGenic ASA Company Overview 87
5.25.1 DiaGenic ASA Pipeline Products & Ongoing Clinical Trials Overview 87
5.26 DiamiR LLC Company Overview 94
5.26.1 DiamiR LLC Pipeline Products & Ongoing Clinical Trials Overview 94
5.27 DiaPat GmbH Company Overview 95
5.27.1 DiaPat GmbH Pipeline Products & Ongoing Clinical Trials Overview 95
5.28 Diaxonhit S.A. Company Overview 96
5.28.1 Diaxonhit S.A. Pipeline Products & Ongoing Clinical Trials Overview 96
5.29 Dr. Grossegger & Drbal GmbH Company Overview 97
5.29.1 Dr. Grossegger & Drbal GmbH Pipeline Products & Ongoing Clinical Trials Overview 97
5.30 DS Pharma Biomedical Co., Ltd. Company Overview 98
5.30.1 DS Pharma Biomedical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 98
5.31 Durin Technologies, Inc. Company Overview 99
5.31.1 Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 99
5.32 Emory University Company Overview 100
5.32.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 100
5.33 Fianostics GmbH Company Overview 101
5.33.1 Fianostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 101
5.34 Gene Solutions LLC Company Overview 102
5.34.1 Gene Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview 102
5.35 GeneNews Limited Company Overview 103
5.35.1 GeneNews Limited Pipeline Products & Ongoing Clinical Trials Overview 103
5.36 Genentech, Inc. Company Overview 105
5.36.1 Genentech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 105
5.37 Georg-August-Universitat Gottingen Company Overview 107
5.37.1 Georg-August-Universitat Gottingen Pipeline Products & Ongoing Clinical Trials Overview 107
5.38 Ghent University Company Overview 110
5.38.1 Ghent University Pipeline Products & Ongoing Clinical Trials Overview 110
5.39 HealthTell, Inc. Company Overview 111
5.39.1 HealthTell, Inc. Pipeline Products & Ongoing Clinical Trials Overview 111
5.40 ICDD-sas Company Overview 112
5.40.1 ICDD-sas Pipeline Products & Ongoing Clinical Trials Overview 112
5.41 Innovative California Biosciences International, Inc. Company Overview 115
5.41.1 Innovative California Biosciences International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 115
5.42 Innovative Health Diagnostics Company Overview 122
5.42.1 Innovative Health Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 122
5.43 Institut National de la Sante et de la Recherche Medicale Company Overview 123
5.43.1 Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview 123
5.44 Instituto de Estructura de la Materia Company Overview 124
5.44.1 Instituto de Estructura de la Materia Pipeline Products & Ongoing Clinical Trials Overview 124
5.45 Integrated Diagnostics Inc. Company Overview 125
5.45.1 Integrated Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 125
5.46 Janssen Pharmaceutica N.V. Company Overview 126
5.46.1 Janssen Pharmaceutica N.V. Pipeline Products & Ongoing Clinical Trials Overview 126
5.47 KineMed, Inc. Company Overview 127
5.47.1 KineMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 127
5.48 Laboratory Corporation of America Holdings Company Overview 128
5.48.1 Laboratory Corporation of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 128
5.49 McGill University Health Center Company Overview 130
5.49.1 McGill University Health Center Pipeline Products & Ongoing Clinical Trials Overview 130
5.50 Memory Dx, LLC Company Overview 131
5.50.1 Memory Dx, LLC Pipeline Products & Ongoing Clinical Trials Overview 131
5.51 Meso Scale Diagnostics LLC Company Overview 132
5.51.1 Meso Scale Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 132
5.52 Myriad Genetics, Inc. Company Overview 133
5.52.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 133
5.53 NanoSomiX, Inc. Company Overview 135
5.53.1 NanoSomiX, Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
5.54 Nanosphere, Inc. Company Overview 137
5.54.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 137
5.55 Neuron Biopharma SA Company Overview 139
5.55.1 Neuron Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview 139
5.56 NeuroQuest, Ltd. Company Overview 141
5.56.1 NeuroQuest, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 141
5.57 Neurotrope Bioscience, Inc. Company Overview 142
5.57.1 Neurotrope Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 142
5.58 NeuroVision Imaging LLC. Company Overview 143
5.58.1 NeuroVision Imaging LLC. Pipeline Products & Ongoing Clinical Trials Overview 143
5.59 Newcastle University Company Overview 144
5.59.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 144
5.60 NextGen Sciences Dx Inc Company Overview 146
5.60.1 NextGen Sciences Dx Inc Pipeline Products & Ongoing Clinical Trials Overview 146
5.61 Novel Bio-spectrum Technologies, Inc. Company Overview 147
5.61.1 Novel Bio-spectrum Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 147
5.62 Oligomerix, inc. Company Overview 148
5.62.1 Oligomerix, inc. Pipeline Products & Ongoing Clinical Trials Overview 148
5.63 OPKO Health, Inc. Company Overview 149
5.63.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 149
5.64 Orasi Medical, Inc. Company Overview 152
5.64.1 Orasi Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 152
5.65 Oregon Health & Science University Company Overview 156
5.65.1 Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 156
5.66 Oryzon Genomics S.A. Company Overview 157
5.66.1 Oryzon Genomics S.A. Pipeline Products & Ongoing Clinical Trials Overview 157
5.67 Oxford Biodynamics Limited Company Overview 159
5.67.1 Oxford Biodynamics Limited Pipeline Products & Ongoing Clinical Trials Overview 159
5.68 PDx BioTech Company Overview 161
5.68.1 PDx BioTech Pipeline Products & Ongoing Clinical Trials Overview 161
5.69 PeriRx LLC Company Overview 162
5.69.1 PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview 162
5.70 Pre Diagnostics AS Company Overview 163
5.70.1 Pre Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 163
5.71 Predemtec GmbH Company Overview 164
5.71.1 Predemtec GmbH Pipeline Products & Ongoing Clinical Trials Overview 164
5.72 ProMIS Neurosciences Inc. Company Overview 165
5.72.1 ProMIS Neurosciences Inc. Pipeline Products & Ongoing Clinical Trials Overview 165
5.73 Proplex Technologies, Llc Company Overview 167
5.73.1 Proplex Technologies, Llc Pipeline Products & Ongoing Clinical Trials Overview 167
5.74 Protagen AG Company Overview 169
5.74.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 169
5.75 Proteome Sciences Plc Company Overview 170
5.75.1 Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 170
5.76 Proteomics International Pty Ltd Company Overview 173
5.76.1 Proteomics International Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 173
5.77 Quanterix Corporation Company Overview 174
5.77.1 Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview 174
5.78 Redox Diagnostics LLC Company Overview 175
5.78.1 Redox Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 175
5.79 Saladax Biomedical, Inc. Company Overview 176
5.79.1 Saladax Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 176
5.80 Satoris, Inc. Company Overview 177
5.80.1 Satoris, Inc. Pipeline Products & Ongoing Clinical Trials Overview 177
5.81 Scout Diagnostics, LLC Company Overview 178
5.81.1 Scout Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview 178
5.82 Singulex, Inc. Company Overview 179
5.82.1 Singulex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 179
5.83 SomaLogic, Inc. Company Overview 180
5.83.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 180
5.84 Takeda Pharmaceuticals International AG Company Overview 181
5.84.1 Takeda Pharmaceuticals International AG Pipeline Products & Ongoing Clinical Trials Overview 181
5.85 The Johns Hopkins University Company Overview 183
5.85.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 183
5.86 The University of Melbourne Company Overview 184
5.86.1 The University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 184
5.87 Trinity College Dublin Company Overview 185
5.87.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 185
5.88 True Diagnostics, Inc. Company Overview 186
5.88.1 True Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 186
5.89 University of California, Irvine Company Overview 187
5.89.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 187
5.90 University of Chicago Company Overview 188
5.90.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 188
5.91 University of Georgia Company Overview 189
5.91.1 University of Georgia Pipeline Products & Ongoing Clinical Trials Overview 189
5.92 University of Luxembourg Company Overview 190
5.92.1 University of Luxembourg Pipeline Products & Ongoing Clinical Trials Overview 190
5.93 University of Nottingham Company Overview 191
5.93.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 191
5.94 University of South Florida Company Overview 192
5.94.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 192
5.95 University of Texas Health Science Center at Houston Company Overview 193
5.95.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 193
5.96 University of Texas Southwestern Medical Center at Dallas Company Overview 195
5.96.1 University of Texas Southwestern Medical Center at Dallas Pipeline Products & Ongoing Clinical Trials Overview 195
5.97 US Biomarkers, Inc. Company Overview 197
5.97.1 US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 197
5.98 Vermillion, Inc. Company Overview 198
5.98.1 Vermillion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 198
5.99 Vitruvian Biomedical, Inc. Company Overview 200
5.99.1 Vitruvian Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 200
5.100 Washington University in St. Louis Company Overview 201
5.100.1 Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview 201
5.101 XRGenomics LTD Company Overview 205
5.101.1 XRGenomics LTD Pipeline Products & Ongoing Clinical Trials Overview 205
5.102 Zoiray Technologies Inc. Company Overview 206
5.102.1 Zoiray Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 206
6 Alzheimer- Recent Developments 207
7 Appendix 213
7.1 Methodology 213
7.2 About GlobalData 215
7.3 Contact Us 216
7.4 Disclaimer 216
【レポート販売概要】
■ タイトル：世界のアルツハイマー検査機器開発動向：医療機器パイプライン分析2015■ 英文：Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月5日
■ 調査会社：GlobalData
■ 商品コード：GDME0143EPD
■ 調査対象地域：グローバル
- CHP用燃料電池の世界市場2016-2020：非住宅用、住宅用About CHP Applications A CHP system involves the simultaneous production of electricity and usable heat from a power plant or heat engine in a single, highly efficient process. It captures the energy produced during power generation and puts it to use for commercial and residential heat production. CHP technology is both cost-effective and environment-friendly. A commercial facility can use CHP to …
- コンタクトレンズの世界市場分析：製品別（RPG、ソフト、ハイブリッド）、デザイン別（丸形、円環状、多焦点･その他）、使用方法別（矯正、治療、美容、補綴、ライフスタイル系）、地域別、セグメント予測、2014-2024The global contact lenses market is expected to reach USD 14.72 billion by 2024, according to a new report by Grand View Research, Inc. The surging acceptance of contact lens in sports activities and outdoor activities is expected to boost the market growth. The increasing acceptance of cosmetic contact lens by media and entertainment segment is further anticipated to bolster the market growth. Gr …
- スマートチケットの世界市場予測・分析2020-2024Global Smart Ticketing Market: About this market Technavio’s smart ticketing market analysis considers sales from transportation and sports and events applications. Our study also finds the sales of smart ticketing in APAC, Europe, North America, South America, and MEA. In 2019, the transportation segment had a significant market share, and this trend is expected to continue over the forecast peri …
- Chevron Corporation：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012Chevron Corporation Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Chevron Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 脂肪族アミンの世界市場分析The global fatty amines market is anticipated to reach USD 2.9 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for high-quality surfactants and emulsifiers due to increased usage of personal and household care products in emerging economies such as Asia Pacific is excepted to steer the market growth in the near future. Fatty amines market growth is mainly …
- 動力用鉛バッテリーの世界市場：産業用フォークリフト、鉄道、鉱業車両Motive Lead-Acid Battery Market 2015-2019 Covering: This market study report segments the global motive lead-acid battery market by application and includes segments like industrial forklifts, railroads, mining, and others. The market study also analyzes the key regions for this market, including Americas, EMEA, and APAC. Leading vendors in this market are Axion Power International, Exide Technolo …
- 発電機販売の世界市場予測（～2020）The generator sales market is expected to grow at a CAGR of 5.85% from 2015 to 2020. It is projected to reach USD 23.36 Billion by 2020 from an estimated value of USD 17.59 Billion in 2015. The generator sales market is driven by growing demand for uninterrupted and reliable power supply across the globe. Countries are regularly facing blackouts, rolling blackouts, or brownouts, which further affe …
- 石油・ガス産業向けデータ管理ソリューションの世界市場The total Oil and Gas Data management market is expected to grow from $6.09 billion in 2015 to $21.22 billion in 2020, at an estimated Compound Annual Growth Rate (CAGR) of 28.4% from 2015 to 2020. The energy companies invest heavily upon seismic software, visualization tools and other digital technologies. The digital upstream, midstream, and downstream activities generate huge volumes of operati …
- MK-8931(Alzheimer’s Disease)：市場予測と分析（～2022）MK-8931(Alzheimer’s Disease) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “MK-8931(Alzheimer’s Disease) - Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapies are re …
- 水処理装置の世界市場：軟水装置、活性炭濾過器、機械式濾過、逆浸透装置、蒸留システム、消毒装置The water treatment systems (PoE) market is projected to grow at a CAGR of 8.52% from 2015 and 2020. The growth in this market is propelled by continuous growth in industrialization, especially in developing economies, increasing water contamination, and increasing awareness about the importance of clean drinking water. The market in the Asia-Pacific region is expected to register the highest grow …
- 紙コップ・紙容器の世界市場2017-2021ABSTRACTAbout Paper Cups and Containers Paper cups are usually coated with PE, which provides stability and heat resistance. However, these PE-coated paper cups are hard to recycle and do not decompose easily, which results in large amounts of paper cups piling up in landfills. Disposable containers are primarily made of paperboard, which is a little thicker than paper. These containers are usuall …
- 無線通信ネットワーク用試験装置の世界市場About Wireless Test Equipment Wireless networks are made of many components including base units, antennas, radio, and cables. These components have functionalities that need to be tested for efficiency before they are deployed in wireless networks. The testing of these components and features is carried out using wireless test equipment, which is widely used to ensure proper network deployment an …
- アメリカのデータセンター建設市場2016About Data Center Construction Market in the US 2016-2020 The construction of a data center encompasses design, architecture, installation of electrical and mechanical systems, and general building works. The US is a suitable location for data center construction due to benefits such as low electricity cost, high network connectivity, tax incentives, ease of business operations, and availability o …
- 世界におけるGPS/GNSS市場2013-2023（地域分析）Synopsis This report offers detailed analysis of the global Military GPS/GNSS market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Military GPS/GNSS market. Summary "The Global Military GPS/GNSS Market 2013-2023 - Country Analysis: Market Profile" provides details of the key markets in each …
- プロテオミクスの世界市場：インサイト、市場機会、市場シェア、市場予測The global proteomics market is estimated to register robust growth during 2016- 2022 and is expected to grow at CAGR of 16.35% during the forecasted period. The proteomics market is segmented on the basis of technology, reagents, services, application and geography. The technology segment is segmented into protein microarray, spectroscopy, x-ray crystallography chromatography, electrophoresis, su …
